Status
Conditions
Treatments
About
Molecular profiling of lung cancers using circulating tumor DNA (ctDNA) in the blood of patients is rapidly becoming established as a useful source of information to aid clinical decision-making. This study is aimed to to compare concordance rate between tissue based cancer panel analysis and blood based cancer panel analysis in lung cancer patients (both by NGS technique).
Full description
This study is comprised of two cohorts as below:
Cohort A: inoperable, untreated, non-small cell lung cancer patients
Cohort B: non-small cell lung cancer patients who are in the treatment with targeted agents including immune checkpoint inhibitors
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Provision of informed consent prior to any study specific procedures, sampling, and analyses
Pathologically confirmed non-small cell lung cancer
Male or female, aged at least 20 years
Matches one of two criteria :
Exclusion criteria
200 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal